US IPOs and Secondary Offerings, IPO Boutique

IPO Boutique

For more than 20 years, we have been providing research, analysis, commentary and ratings on US Equity Capital Markets to institutional investors (US IPOs and Secondary Offerings). Our vast network of contacts across the Equity Capital Markets and attention-to-detail sets us apart from our competitors.

Since 2012, we have achieved a successful hit rating on 89% of Buy-rated IPOs. The collective “Buy” ratings averaged a first trade of 16.3% above issue.Our Neutral Rated Deals averaged just 2% above the issue price at first trade.

Our written research includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

In addition, we provide a high-touch premium desk access which includes analyst access, as well as real time insights on US IPOs as well as secondary offerings.

US IPOs and Secondary Offerings

Suja Life (SUJA): PSP Backed Beverage-Maker Sets Terms for IPO Seeking $927m Valuation

Suja Life (SUJA): Peeking at the Prospectus of the Next Beverage-Related IPO

Suja Life (SUJA): Growth Platform or Fully Valued Beverage Trade?

IPOs and Secondary Offerings

Equity Capital Markets

<ul>
<li>Suja Life opened 14.3% below IPO price, marking one of the weakest first-trade performances among 2026 IPOs.</li>
<li>Investor concerns centered on premium valuation, elevated leverage, and intense competition within functional and wellness beverages.</li>
<li>Weak aftermarket support and fading volume suggest continued near-term selling pressure and cautious institutional sentiment.</li>
</ul>


Suja Life opened 14.3% below IPO price, marking one of the weakest first-trade performances among 2026 IPOs.
Investor concerns centered on premium valuation, elevated leverage, and intense competition within functional and wellness beverages.
Weak aftermarket support and fading volume suggest continued near-term selling pressure and cautious institutional sentiment.


Suja Life (SUJA): ウェルネス疲れ？Suja Life、2026年最悪のIPOデビューの一つとなる